SCHEMBL15215258

SCHEMBL15215258

c1nnnn1[C@H]1[C@@H]2CNC[C@@H]21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459432 1.00
SCHEMBL9934510 0.80
SCHEMBL9933548 0.72 SMN1; SMN2 (0.32)
SCHEMBL15432269 0.69
SCHEMBL16903798 0.69
Hydrochloric Acid SCHEMBL16894707 0.67
SCHEMBL9965938 0.67 ALDH1A1 (0.43)
SCHEMBL9965912 0.64 GAA (0.41)
SCHEMBL18377698 0.63 KDM5A (0.32)
SCHEMBL29220807 0.60 SLC6A2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933102-B2 Pyrrolidine derived β3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2015-01-13 US disclosed
US-8933102-B2 Pyrrolidine derived β3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2015-01-13 US disclosed
US-20130225599-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Life Technologies Corporation (US) 2013-08-29 US disclosed
US-20130225599-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Life Technologies Corporation (US) 2013-08-29 US disclosed